etranacogene dezaparvovec

Italy

Drugs containing this active substance

  • HEMGENIX

    It is a gene therapy medicinal product used for the treatment of severe and moderately severe hemophilia B (congenital factor IX deficiency) in adults who have not developed antibodies against factor IX.

    Form: solution for infusion, concentrate

    Active substance Dosage
    etranacogene dezaparvovec -

    ATC: B02BD16

    Manufacturer: CSL BEHRING GMBH